{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:13:19Z","timestamp":1793365999947,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jgar.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T11:30:57Z","timestamp":1554895857000},"page":"230-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["First multicentre report of in vitro resistance rates in candidaemia isolates in Turkey"],"prefix":"10.1016","volume":"18","author":[{"given":"Sevtap","family":"Arikan-Akdagli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolunay","family":"G\u00fclmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilg\u00fcn","family":"\u00c7erik\u00e7io\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Doluca Dereli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuman","family":"Birinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015einasi Taner","family":"Y\u0131ld\u0131ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beyza","family":"Ener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"\u00d6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek Ye\u015fim","family":"Metin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyha","family":"Hilmio\u011flu-Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Kalkanc\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nedret","family":"Ko\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zayre","family":"Erturan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"F\u0131nd\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2019.04.003_bib0005","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijantimicag.2017.03.028","article-title":"CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program","volume":"50","author":"Pfaller","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2019.04.003_bib0010","doi-asserted-by":"crossref","first-page":"e0146909","DOI":"10.1371\/journal.pone.0146909","article-title":"Epidemiology and microbiologic characterization of nosocomial candidemia from a Brazilian national surveillance program","volume":"11","author":"Doi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2019.04.003_bib0015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1186\/s12879-017-2825-7","article-title":"Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten university hospitals in Iran: comparison of colonizing and infecting isolates","volume":"17","author":"Badiee","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jgar.2019.04.003_bib0020","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1128\/JCM.01998-13","article-title":"Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain","volume":"51","author":"Bassetti","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2019.04.003_bib0025","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s10096-014-2194-8","article-title":"Species distribution and in vitro antifungal susceptibility profiles of yeast isolates from invasive infections during a Portuguese multicenter survey","volume":"33","author":"Faria-Ramos","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2019.04.003_bib0030","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/13693780903410386","article-title":"Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea","volume":"48","author":"Jung","year":"2010","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2019.04.003_bib0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/myc.12816","article-title":"Epidemiology of fungaemia in Sweden: a nationwide retrospective observational survey","volume":"61","author":"Klingspor","year":"2018","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2019.04.003_bib0040","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jac\/dkt330","article-title":"Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study","volume":"69","author":"Liu","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.04.003_bib0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10096-014-2240-6","article-title":"Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study","volume":"34","author":"Minea","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2019.04.003_bib0050","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s15010-013-0432-0","article-title":"Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)","volume":"41","author":"Montagna","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.jgar.2019.04.003_bib0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.diagmicrobio.2014.05.021","article-title":"Sentinel surveillance of invasive candidiasis in Spain: epidemiology and antifungal susceptibility","volume":"81","author":"Nieto","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2019.04.003_bib0060","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/jac\/dks019","article-title":"Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey","volume":"67","author":"Pem\u00e1n","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.04.003_bib0065","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/JCM.05474-11","article-title":"Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey","volume":"49","author":"Pem\u00e1n","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2019.04.003_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175172","article-title":"A multi-centric study of Candida bloodstream infection in Lima-Callao, Peru: species distribution, antifungal resistance and clinical outcomes","volume":"12","author":"Rodriguez","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2019.04.003_bib0075","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/mmy\/myv114","article-title":"Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region","volume":"54","author":"Tan","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2019.04.003_bib0080","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10096-016-2841-3","article-title":"Epidemiology and reporting of candidaemia in Belgium: a multi-centre study","volume":"36","author":"Trouve","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2019.04.003_bib0085","doi-asserted-by":"crossref","first-page":"e0118770","DOI":"10.1371\/journal.pone.0118770","article-title":"Antifungal susceptibilities of bloodstream isolates of Candida species from nine hospitals in Korea: application of new antifungal breakpoints and relationship to antifungal usage","volume":"10","author":"Won","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2019.04.003_bib0090","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/jac\/dku460","article-title":"Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance","volume":"70","author":"Xiao","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.04.003_bib0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.diagmicrobio.2013.03.003","article-title":"Species distribution and drug susceptibilities of Candida isolates in TSARY 2010","volume":"76","author":"Yang","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2019.04.003_bib0100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.diagmicrobio.2016.09.009","article-title":"The distribution and drug susceptibilities of clinical Candida species in TSARY 2014","volume":"86","author":"Zhou","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2019.04.003_bib0105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","article-title":"Echinocandin resistance: an emerging clinical problem?","volume":"27","author":"Arendrup","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jgar.2019.04.003_bib0110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3109\/13693786.2011.618996","article-title":"Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria","volume":"50","author":"Ozhak-Baysan","year":"2012","journal-title":"Med Mycol"},{"key":"10.1016\/j.jgar.2019.04.003_bib0115","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/236903","article-title":"In vitro susceptibility of Candida species to four antifungal agents assessed by the reference broth microdilution method","volume":"2013","author":"Eksi","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.jgar.2019.04.003_bib0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5578\/mb.63991","article-title":"Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates [in Turkish]","volume":"52","author":"Dalyan Cilo","year":"2018","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.jgar.2019.04.003_bib0125","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s11046-018-0261-x","article-title":"Genetic diversity and antifungal susceptibility of Candida parapsilosis sensu stricto isolated from bloodstream infections in Turkish patients","volume":"183","author":"Hilmioglu-Polat","year":"2018","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jgar.2019.04.003_bib0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5578\/mb.10682","article-title":"Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance [in Turkish]","volume":"50","author":"Karab\u0131\u00e7ak","year":"2016","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.jgar.2019.04.003_bib0135","doi-asserted-by":"crossref","first-page":"428","DOI":"10.5578\/mb.26544","article-title":"Comparison of microdilution and disk diffusion methods for the detection of fluconazole and voriconazole susceptibility against clinical Candida glabrata isolates and determination of changing susceptibility with new CLSI breakpoints [in Turkish]","volume":"50","author":"Haz\u0131rolan","year":"2016","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.jgar.2019.04.003_bib0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jiac.2016.06.012","article-title":"Antifungal susceptibilities of Candida species isolated from urine culture","volume":"22","author":"Toka \u00d6zer","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jgar.2019.04.003_bib0145","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/myc.12209","article-title":"An investigation of Candida species isolated from blood cultures during 17 years in a university hospital","volume":"57","author":"Kazak","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.jgar.2019.04.003_bib0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11046-011-9413-y","article-title":"Evaluation of antifungal susceptibility testing with microdilution and Etest methods of Candida blood isolates","volume":"172","author":"Metin","year":"2011","journal-title":"Mycopathologia"},{"key":"10.1016\/j.jgar.2019.04.003_bib0155","series-title":"Medically important fungi: a guide to identification","author":"Larone","year":"2011"},{"key":"10.1016\/j.jgar.2019.04.003_bib0160","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1128\/JCM.00263-17","article-title":"Validation of a new web application for identification of fungi by use of matrix-assisted laser desorption ionization\u2013time of flight mass spectrometry","volume":"55","author":"Normand","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2019.04.003_bib0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.mimet.2015.02.004","article-title":"Current methods for identifying clinically important cryptic Candida species","volume":"111","author":"Criseo","year":"2015","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.jgar.2019.04.003_bib0170","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.biotechadv.2013.11.002","article-title":"Identification of fungal microorganisms by MALDI-TOF mass spectrometry","volume":"32","author":"Chalupova","year":"2014","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.jgar.2019.04.003_bib0175","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard\u2014third edition","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.jgar.2019.04.003_bib0180","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1128\/AAC.01519-13","article-title":"Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?","volume":"57","author":"Espinel-Ingroff","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.04.003_bib0185","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2017"},{"key":"10.1016\/j.jgar.2019.04.003_bib0190","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JCM.00937-12","article-title":"Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2019.04.003_bib0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12941-016-0153-1","article-title":"Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey","volume":"15","author":"Dagi","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jgar.2019.04.003_bib0200","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/jac\/dkw091","article-title":"Emergence of azole-resistant Candida parapsilosis causing bloodstream infection: results from laboratory-based sentinel surveillance in South Africa","volume":"71","author":"Govender","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.04.003_bib0205","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.diagmicrobio.2018.05.001","article-title":"Impact of high MIC of fluconazole on outcomes of Candida glabrata bloodstream infection: a retrospective multicenter cohort study","volume":"92","author":"Ko","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2019.04.003_bib0210","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00591-18","article-title":"Clonal spread of Candida glabrata bloodstream isolates and fluconazole resistance affected by prolonged exposure: a 12-year single-center study in Belgium","volume":"62","author":"Goemaere","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2019.04.003_bib0215","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/jac\/dkv140","article-title":"Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations","volume":"70","author":"Jensen","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651930092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651930092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:54:00Z","timestamp":1761990840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371651930092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":43,"alternative-id":["S221371651930092X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.04.003","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First multicentre report of in vitro resistance rates in candidaemia isolates in Turkey","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Antimicrobial Chemotherapy. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}